Fresh mechanistic insights into the impact of profound ANGPTL3 deficiency are provided in a study of apoB48, apoB100 and TG metabolism in chylomicrons, VLDL1, VLDL2, IDL and LDL in individuals with ANGPTL3 homozygous or heterozygous loss of function (LOF) variants, compared with controls.
